Halozyme Therapeutics
HALO
#2055
Rank
C$10.84 B
Marketcap
$88.06
Share price
0.28%
Change (1 day)
58.14%
Change (1 year)

EPS for Halozyme Therapeutics (HALO)

EPS in 2023 (TTM): $2.35

According to Halozyme Therapeutics's latest financial reports the company's current EPS (TTM) is $2.51. In 2022 the company made an earnings per share (EPS) of $2.13 a decrease over its 2021 EPS that were of $4.11.

EPS history for Halozyme Therapeutics from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.359.93%
2022$2.13-48.07%
2021$4.11196.88%
2020$1.38-292%
2019-$0.72-9.09%
2018-$0.79-237.5%
2017$0.58-149.38%
2016-$1.17211.54%
2015-$0.37-52.73%
2014-$0.79-24.66%
2013-$1.0548.98%
2012-$0.71145%
2011-$0.29-64.29%
2010-$0.81-17.65%
2009-$0.989.68%
2008-$0.8993.75%
2007-$0.4633.33%
2006-$0.35-4%
2005-$0.36-3.85%
2004-$0.37-13.33%
2003-$0.4383.59%
2002-$0.24

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$0.27-110.92%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.83 212.03%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.38 194.25%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.68 6.90%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.59 82.77%๐Ÿ‡ซ๐Ÿ‡ท France
$20.31 709.50%๐Ÿ‡บ๐Ÿ‡ธ USA